Close Menu

NEW YORK (GenomeWeb) — Dutch laboratory equipment supplier Bioké said this week that it has signed an agreement to distribute certain of Omni Life Science's cellular analysis products in the Netherlands, Belgium, and Luxembourg.

The deal specifically covers Bremen, Germany-based OLS' CERO benchtop 3D cell incubator and bioreactor, as well as its CASY cell counter and analyzer. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.